Ignite Creation Date:
2024-05-06 @ 7:51 PM
Last Modification Date:
2024-10-26 @ 3:15 PM
Study NCT ID:
NCT06162286
Status:
RECRUITING
Last Update Posted:
2024-06-14
First Post:
2023-11-30
Brief Title:
A Phase 3b Randomized Double-blind Multi-center Study to Compare the Safety and Efficacy of Omadacycline to Moxifloxacin for Treating Adult Subjects With CABP
Sponsor:
Zai Lab Hong Kong Ltd
Organization:
Zai Lab Hong Kong Ltd
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-11-17
Start Date Type:
ACTUAL
Primary Completion Date:
2025-01-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-11-30
Completion Date Type:
ESTIMATED
First Submit Date:
2023-11-30
First Submit QC Date:
December 7 2023
Study First Post Date:
2023-12-08
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-06-13
Last Update Post Date:
2024-06-14
Last Update Post Date Type:
ACTUAL